@IMPORTANTrial_Community

Community platform of the @IMPORTANTrial EU Project. IMPORTANT has received funding from @HorizonEU #Cancer #BreastCancer #Trial

[IMPORTANT EU Project @IMPORTANTrial]

Happy to share our project's May 2026 newsletter:
#HorizonEU #Breastcancer @IMPORTANTrialC

[ESMO - Eur. Oncology @myESMO]

🙌 #ESMOBreast26: Welcome to your international, multidisciplinary meeting, to explore the most up-to-date science in breast cancer, collaborate with global experts to share real-world experiences and help us build the future of breast cancer care.

🔗 https://t.co/KLUUnz4u0n

#esmomeetings

[IMPORTANT EU Project @IMPORTANTrial]

Our project's latest work at #GEC2026 7–8 May. Frailty-aware dose optimisation in geriatric oncology using Markov Decision Processes https://t.co/EijtCb8Onj #HorizonEU #Breastcancer
@IMPORTANTrialC

[OncoDailyBreast @OncoDailyBreast]

🔬 HR+ BREAST CANCER: THE TRIALS THAT CHANGED EVERYTHING

https://t.co/8hDBs1Hf04

The treatment of HR+/HER2− early breast cancer has been completely redefined over the past decade, and it all comes down to a few GAME-CHANGING trials. 🚀

🔹 TAILORx → Many patients can SKIP chemotherapy safely
🔹 monarchE → Abemaciclib + endocrine therapy improves survival — YES, survival 🔥
🔹 NATALEE → CDK4/6 inhibitors move EARLIER and reach MORE patients

This is no longer one-size-fits-all medicine.
This is PRECISION oncology in action.

📊 Less overtreatment.
📊 Better outcomes.
📊 Smarter decisions.

📌 Part of our SPECIAL SERIES on the historical trials that changed breast oncology, the studies that shaped modern care.

#BreastCancer #Oncology #ClinicalTrials #PrecisionMedicine #TNBC #HRPositive #OncoDaily 🚀

[IMPORTANT EU Project @IMPORTANTrial]

Great to see our coordinator Antonios Valachis presenting at the SOLTI course on real-world evidence in breast cancer https://t.co/hZOnbQkpQW
https://t.co/iSb2aPd96u
#RWE #Oncology @IMPORTANTrialC

[IMPORTANT EU Project @IMPORTANTrial]

New 🎥from our #Trial: Why dose optimisation matters for older people living with advanced breast cancer?
#Cancer #BreastCancer @IMPORTANTrialC @HorizonEU

[IMPORTANT EU Project @IMPORTANTrial]

EU Cancer Mission Project: IMPORTANT – Optimising Treatment for Older Pa... https://t.co/MWZ3IgH1So via @YouTube

[Annals of Oncology @Annals_Oncology]

🆕February issue now online:
👉Estrogens and breast cancer
👉Results of the PAOLA-1/ENGOT-ov25 trial
👉5 year results of the OPERA trial
https://t.co/YxmhZWD6Ar

[IMPORTANT EU Project @IMPORTANTrial]

Excited to share highlights from the 3rd #IMPORTANT project plenary meeting, held #Athens 🇬🇷 May 27th! Clinical sites, SMEs, universities, & patient advocates joined forces to advance our mission of enhancing #breastcancer treatment for older patients through a #clinical #trial

[IMPORTANT EU Project @IMPORTANTrial]

We r part of the #HorizonEU Diagnostics and Treatment Cluster https://t.co/PkywXZjFU9

[IMPORTANT EU Project @IMPORTANTrial]

Our project is one of the projects under the #HorizonEU Diagnostics and Treatment Cluster. For more info check https://t.co/nDyQC5Gsj5

[IMPORTANT EU Project @IMPORTANTrial]

Excited to share our new #publication Implementing #geriatric assessment for dose optimization of CDK4/6 inhibitors in older #BreastCancer patients https://t.co/aS7RXTfbG8